Le Cacheux, Corentin http://orcid.org/0009-0001-9127-3738
Couturier, Audrey
Sortais, Clara
Houot, Roch
Péré, Morgane
Gastinne, Thomas
Seguin, Amélie
Reignier, Jean
Lascarrou, Jean-Baptiste
Tadié, Jean-Marc
Quelven, Quentin
Canet, Emmanuel
Article History
Received: 12 October 2023
Accepted: 9 January 2024
First Online: 31 January 2024
Declarations
:
: The study was approved by the ethics committee of the French Intensive Care Society (CE SRLF 22-044) on July 7, 2022. In accordance with French law on retrospective studies of anonymized healthcare data, informed consent was not required.
: Not applicable.
: EC has received lecturer and conference-speaker fees, as well as reimbursements of travel and accommodation expenses related to attending scientific meetings, from Gilead, Shionogi, and Sanofi-Genzyme. JBL has received lecturer and conference-speaker fees from BD and Zoll. RH reports honoraria from Kite/Gilead, Novartis, Incyte, Janssen, MSD, Takeda and Roche; and the receipt of consultancy fees from Kite/Gilead, Novartis, Bristol-Myers Squibb/Celgene, ADC Therapeutics, Incyte, and Miltenyi Biotec. None of the other authors have relevant financial or non-financial interests to disclose.